BioMedReports: Small Biotech Firms (Amex: HEB)(Nasdaq: NVAX) Could Reap Benefits From Government's Flu Vaccine Initiative
Biomedical news portal takes a closer look at companies that could benefit from the U.S. government's billion dollar vaccine initiative.
View full press release